Formulations Of Mazindol

Patent No. EP2552210 (titled "Formulations Of Mazindol") was filed by Supernus Pharmaceuticals on Mar 30, 2011. The application was issued on Dec 20, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGIMBEAUSep 20, 2018REGIMBEAU

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2552210

SUPERNUS PHARMACEUTICALS
Application Number
EP11763348A
Filing Date
Mar 30, 2011
Status
Revoked
Mar 29, 2024
Publication Date
Dec 20, 2017